Company / Total Assets
KYNTRA BIO, INC. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$119.6M
FY2025
5-year range
$119.6M / $826.8M
FY2021-FY2025
Trend
-44.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has declined for 4 consecutive years, from $827M in FY2021 to $120M in FY2025.
Based on SEC 10-K filings.
$120M in FY2025 with a 5-year CAGR of -32.1%.
Declined from $424M to $120M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -41.9%
- 5-Year CAGR
- -32.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- KYNTRA BIO, INC.'s total assets has declined for 4 consecutive years.
- 5-year CAGR of -32.1%, indicating a declining trend.
- In FY2025, total assets decreased 44.3% year-over-year.
- Peak total assets was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score -3.33 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $119.6M | -44.3% |
| FY2024 | $214.5M | -49.3% |
| FY2023 | $423.5M | -30.6% |
| FY2022 | $610.1M | -26.2% |
| FY2021 | $826.8M | +0.0% |
| FY2020 | $826.8M | -3.6% |
| FY2019 | $857.4M | -2.6% |
| FY2018 | $880.6M | -2.0% |
| FY2017 | $898.6M | +91.4% |
| FY2016 | $469.6M | -0.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026